Can a single-port robot be safely used for robotic total gastrectomy for advanced gastric cancer? First experience using the da Vinci SP platform

Cui, Hao; Cui, Jianxin; Zhang, Kecheng; Liang, Wenquan; Li, Shuyan; Huang, Jun; Chen, Lin; Wei, Bo

doi:10.1093/gastro/goac023

Cited by 6 publications

(4 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among the included studies, 36 were case reports [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 ], 52 were noncomparative studies [ 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 ,…”

Section: Resultsmentioning

confidence: 99%

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

et al. 2023

View full text Add to dashboard Cite

Background and Objectives: Robotic surgery has been widely adopted in general surgery worldwide but access to this technology is still limited to a few hospitals. With the recent introduction of new robotic platforms, several studies reported the feasibility of different surgical procedures. The aim of this systematic review is to highlight the current clinical practice with the new robotic platforms in general surgery. Materials and Methods: A grey literature search was performed on the Internet to identify the available robotic systems. A PRISMA compliant systematic review was conducted for all English articles up to 10 February 2023 searching the following databases: MEDLINE, EMBASE, and Cochrane Library. Clinical outcomes, training process, operating surgeon background, cost-analysis, and specific registries were evaluated. Results: A total of 103 studies were included for qualitative synthesis after the full-text screening. Of the fifteen robotic platforms identified, only seven were adopted in a clinical environment. Out of 4053 patients, 2819 were operated on with a new robotic device. Hepatopancreatobiliary surgery specialty performed the majority of procedures, and the most performed procedure was cholecystectomy. Globally, 109 emergency surgeries were reported. Concerning the training process, only 45 papers reported the background of the operating surgeon, and only 28 papers described the training process on the surgical platform. Only one cost-analysis compared a new robot to the existing reference. Two manufacturers promoted a specific registry to collect clinical outcomes. Conclusions: This systematic review highlights the feasibility of most surgical procedures in general surgery using the new robotic platforms. Adoption of these new devices in general surgery is constantly growing with the extension of regulatory approvals. Standardization of the training process and the assessment of skills’ transferability is still lacking. Further studies are required to better understand the real clinical and economical benefit.

show abstract

Section: Resultsmentioning

confidence: 99%

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Successful case reports of robotic total gastrectomy (RTG) for locally progressive gastric cancer using the da Vinci SP platform establish the feasibility of SP robotic application for total gastrectomy. 1 The SHURUI SP surgical robot is a new robot platform. At present, the robot has only been approved for marketing by the National Medical Products Administration of China, and its safety and efficacy for radical prostatectomy have been proven.…”

Section: Introductionmentioning

confidence: 99%

“…However, single‐port (SP) robots have been developed to achieve less surgical trauma and more aesthetically pleasing surgical incisions. Successful case reports of robotic total gastrectomy (RTG) for locally progressive gastric cancer using the da Vinci SP platform establish the feasibility of SP robotic application for total gastrectomy 1 . The SHURUI SP surgical robot is a new robot platform.…”

Section: Introductionmentioning

confidence: 99%

A novel single‐port robot for total gastrectomy to treat gastric cancer: A case report (with video)

Luo,

Yang,

Bao

et al. 2024

Asian J Endoscop Surgery

View full text Add to dashboard Cite

Multiport robots are now widely used for total gastrectomy for gastric cancer, while there is almost a void of research on whether single‐port (SP) robots can be used for total gastrectomy. Here, we report a case of a 75‐year‐old female patient who was diagnosed with gastric cardia adenocarcinoma by gastroscopy and underwent total gastrectomy assisted by the SHURUI SP robot. We successfully accomplished total gastrectomy and D2 lymph node dissection using the novel SP robotic platform. The patient was discharged from the hospital successfully with no complications during or after the surgery. Pathologic diagnosis showed adenocarcinoma of the gastric mucosa with partial signet‐ring cell carcinoma, and no metastasis was found in the 29 cleared lymph nodes. The use of the SHURUI SP robot for total gastrectomy in treating gastric cancer is both technically feasible and safe.

show abstract

“…Minimally invasive gastrectomy (MIG) has several advantages such as smaller surgical incision and faster post-operative recovery [ 9 ]. Most studies also demonstrated the comparable short-term and long-term outcomes between MIG and open gastrectomy (OG) [ 10 , 11 ].…”

Section: Introductionmentioning

confidence: 99%

Safety and feasibility of minimally invasive gastrectomy after neoadjuvant immunotherapy for locally advanced gastric cancer: a propensity score-matched analysis in China

Cui,

Liang,

Cui

et al. 2023

Gastroenterology Report

Self Cite

View full text Add to dashboard Cite

Background The effect of neoadjuvant immunotherapy on minimally invasive gastrectomy (MIG) for locally advanced gastric cancer (LAGC) remains controversial. This study aimed to compare short-term outcomes between MIG after neoadjuvant chemo-immunotherapy (NICT-MIG) and MIG after neoadjuvant chemotherapy alone (NCT-MIG), and determine risk factors for post-operative complications (POCs). Methods This retrospective study included clinicopathologic data from 193 patients who underwent NCT-MIG or NICT-MIG between January 2020 and February 2023 in the Department of General Surgery, Chinese People’s Liberation Army General Hospital First Medical Center (Beijing, China). Propensity score-matched analysis at a ratio of 1:2 was performed to reduce bias from confounding patient-related variables and short-term outcomes were compared between the two groups. Results The baseline characteristics were comparable between 49 patients in the NICT-MIG group and 86 patients in the NCT-MIG group after propensity score matching. Objective and pathologic complete response rates were significantly higher in the NICT-MIG group than in the NCT-MIG group (P < 0.05). The overall incidence of treat-related adverse events, intraoperative bleeding, operation time, number of retrieved lymph nodes, time to the first flatus, post-operative duration of hospitalization, overall morbidity, and severe morbidity were comparable between the NCT-MIG and NICT-MIG groups (P > 0.05). By multivariate logistic analysis, estimated blood loss of >200 mL (P = 0.010) and prognostic nutritional index (PNI) score of <45 (P = 0.003) were independent risk factors for POCs after MIG following neoadjuvant therapy. Conclusions Safety and feasibility of NICT were comparable to those of NCT in patients undergoing MIG for LAGC. Patients with an estimated blood loss of >200 mL or a PNI score of <45 should be carefully evaluated for increased POCs risk.

show abstract

Can a single-port robot be safely used for robotic total gastrectomy for advanced gastric cancer? First experience using the da Vinci SP platform

Cited by 6 publications

References 39 publications

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

New Robotic Platforms in General Surgery: What’s the Current Clinical Scenario?

A novel single‐port robot for total gastrectomy to treat gastric cancer: A case report (with video)

Safety and feasibility of minimally invasive gastrectomy after neoadjuvant immunotherapy for locally advanced gastric cancer: a propensity score-matched analysis in China

Contact Info

Product

Resources

About